Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 331 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Observational data collection. Clear all

Conditions: Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed, hATTR
Interventions: Treatment of transthyretin (ATTR) amyloidosis in observational study setting; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 1,850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 33
States / cities: La Jolla, California • Los Angeles, California • San Francisco, California + 24 more

Conditions: Knee Prosthesis
Interventions: Stryker posterior cruciat retaining (PCR) total knee arthroplasty (TKA), Zimmer PCR TKA; Device
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 40 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 4
States / cities: Knoxville, Tennessee

Conditions: Head And Neck Cancer
Interventions: Questionnaires & Study Visit; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: X-Linked Adrenoleukodystrophy (X-ALD), Cerebral Adrenoleukodystrophy (CALD), Adrenoleukodystrophy (ALD)
Interventions: Allo-HSCT; Genetic
Lead sponsor: Genetix Biotherapeutics Inc.; Industry
Eligibility: Up to 17 Years · Male only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 6
States / cities: Los Angeles, California • Palo Alto, California • Boston, Massachusetts + 3 more

Conditions: Cardiovascular Diseases, Cardiac Arrhythmia, Atrial Fibrillation
Interventions: Screening, detection and referral for atrial fibrillation; Device
Lead sponsor: American Pharmacists Association Foundation; Other
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Epilepsy
Interventions: Not listed
Lead sponsor: Cyberonics, Inc.; Industry
Eligibility: 6 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Data Collection
Interventions: Not listed
Lead sponsor: GRAIL, Inc.; Industry
Eligibility: Not listed
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Menlo Park, California

Conditions: Carbon Monoxide Poisoning
Interventions: Observational data collection; Device
Lead sponsor: Nonin Medical, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Hemophagocytic Lymphohistiocytoses
Interventions: Blood Draws Data Collection; Other
Lead sponsor: Swedish Orphan Biovitrum; Industry
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Liver
Interventions: Questionnaires; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN)
Interventions: Ziconotide; Drug
Lead sponsor: Christian Hospital Northeast Northwest; Other
Eligibility: 18 Years to 100 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Breast Cancer, Lymphoma, Hodgkin's Lymphoma
Interventions: surveys, Blood draw, Transvaginal ultrasounds; Behavioral · Other · Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 475 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Infertility
Interventions: Eeva™ Test; Device
Lead sponsor: Progyny, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 6
States / cities: Chicago, Illinois • Carmel, Indiana • Iowa City, Iowa + 3 more

Conditions: Head and Neck Carcinoma
Interventions: Quality-of-Life Assessment, Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Prostate Carcinoma
Interventions: Focus group, Clinician Interviews, Intervention testing, Survey, Follow-up Interview, Virtual Health Intervention; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: Up to 80 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Multiple Sclerosis
Interventions: Blood sample collection for coagulation profile; Diagnostic Test
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Pediatric ALL, Adolescent
Interventions: Observation; Other
Lead sponsor: MultiCare Health System Research Institute; Other
Eligibility: 3 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Puyallup, Washington

Conditions: Ulcerative Colitis, Pediatric, Inflammatory Bowel Diseases, Crohn Disease
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 1 Year to 18 Years
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Chapel Hill, North Carolina • Charlotte, North Carolina • Durham, North Carolina + 1 more

Conditions: Tremor, Essential Tremor, Parkinson Disease, Radiosurgery, Quality of Life
Interventions: Questionnaires / Observational Assessments; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Primary Health Care, Aged, Clinical Information
Interventions: Patient Overview Document; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 65 Years and older
Enrollment: 2,332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Preeclampsia (PE)
Interventions: Not listed
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 6,550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Glendale, Arizona • Newark, Delaware • Miami, Florida + 15 more

Conditions: Major Depression, Dysthymia
Interventions: Harmonized Depression Outcome Measures; Other
Lead sponsor: OM1, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 953 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Lexington, Kentucky

Conditions: Acute Disease, Disease Progression, Critical Illness, Biomarkers, Aging, Digital Health, Wearable Electronic Devices, Remote Patient Monitoring
Interventions: Multimodal Digital Biomarker Monitoring; Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2039
U.S. locations: 1
States / cities: New York, New York

Conditions: Caregiver, Health Care Provider, Malignant Neoplasm, Physician
Interventions: Interview, Quality-of-Life Assessment, Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 6,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

In Vivo Kinematics Comparison of Stryker or Zimmer Total Knee Arthroplasty

Spousal Support in Head and Neck Cancer

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Solutions for Atrial Fibrillation Edvocacy (SAFE)

Physiological and Biomechanical Data Collection Study in Epilepsy Subjects

The Galleri® Community Research Program

Suspected Cases of Carbon Monoxide Poisoning in the ED

Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis

Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Eeva System Imaging Study

Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers

iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

VALIDATE: Factor VIII Trending for MS Relapse

Pediatric Normative Markerless Movement Analysis

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

Human Factors Intervention to Reduce Risk in Primary Care of the Elderly

Non-Invasive Preeclampsia Screening and Biobank

Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry

Multimodal Digital Biomarker Prediction of Acute Clinical Deterioration

New Assessment System in Measuring Symptom Distress in Cancer Patients